These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
669 related items for PubMed ID: 19755387
1. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Nobusawa S, Watanabe T, Kleihues P, Ohgaki H. Clin Cancer Res; 2009 Oct 01; 15(19):6002-7. PubMed ID: 19755387 [Abstract] [Full Text] [Related]
2. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T, Reifenberger G, Weller M, Loeffler M, von Deimling A. Acta Neuropathol; 2010 Dec 01; 120(6):707-18. PubMed ID: 21088844 [Abstract] [Full Text] [Related]
4. The definition of primary and secondary glioblastoma. Ohgaki H, Kleihues P. Clin Cancer Res; 2013 Feb 15; 19(4):764-72. PubMed ID: 23209033 [Abstract] [Full Text] [Related]
6. IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme. Kalkan R, Atli Eİ, Özdemir M, Çiftçi E, Aydin HE, Artan S, Arslantaş A. Gene; 2015 Jan 01; 554(1):81-6. PubMed ID: 25455102 [Abstract] [Full Text] [Related]
7. IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance. Thota B, Shukla SK, Srividya MR, Shwetha SD, Arivazhagan A, Thennarasu K, Chickabasaviah YT, Hegde AS, Chandramouli BA, Somasundaram K, Santosh V. Am J Clin Pathol; 2012 Aug 01; 138(2):177-84. PubMed ID: 22904127 [Abstract] [Full Text] [Related]
9. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G. Clin Cancer Res; 2007 May 01; 13(9):2606-13. PubMed ID: 17473190 [Abstract] [Full Text] [Related]
13. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes. Seiz M, Tuettenberg J, Meyer J, Essig M, Schmieder K, Mawrin C, von Deimling A, Hartmann C. Acta Neuropathol; 2010 Aug 01; 120(2):261-7. PubMed ID: 20514489 [Abstract] [Full Text] [Related]